Chemicalstructure.jpg (Bivalirudin Injection 1)
Bivalirudin Injection, Solution
Product Images NDC 42023-622
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 42023-622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton Image (Bivalirudin Injection 2)
The text provides information about a medication called Bivalirudin Injection. It is a prescription-only medication used for intravenous use. The medication comes in a single-dose vial containing 250 mg of bivalirudin in 50 mL of solution, which is equivalent to a concentration of 5 mg/mL. The vial is ready to use and should not be diluted. Any unused portion should be discarded.
The solution contains bivalirudin, sodium acetate trihydrate, polyethylene glycol 400, and water for injection. The pH of the solution may have been adjusted using sodium hydroxide and/or glacial acetic acid. The recommended dosage should be obtained from the prescribing information.
The Bivalirudin Injection vials should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F), but once taken out of the refrigerator, they can be stored at room temperature (20°C to 25°C or 68°F to 71°F) for up to 72 hours. It should be kept away from excess heat.
The medication is distributed by Par Pharmaceutical in Chestnut Ridge, NY, and is a product of India. The provided codes are NDC 42023-622-01 and Code No.: AP/DRUGS/103/97.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
